Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$1.61 USD
-0.39 (-19.50%)
Updated Aug 7, 2024 03:59 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Ayr Wellness Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 464 | 466 | 358 | 155 | 75 |
Cost Of Goods | 261 | 275 | 220 | 52 | 49 |
Gross Profit | 202 | 190 | 138 | 103 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 240 | 433 | 194 | 87 | 64 |
Income After Depreciation & Amortization | -37 | -243 | -56 | 16 | -37 |
Non-Operating Income | 31 | 63 | 85 | -164 | -119 |
Interest Expense | 39 | 31 | 17 | 4 | 3 |
Pretax Income | -46 | -210 | 12 | -152 | -159 |
Income Taxes | 47 | 45 | 29 | 24 | 5 |
Minority Interest | -7 | -10 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -93 | -255 | -17 | -176 | -164 |
Extras & Discontinued Operations | -186 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -272 | -245 | -17 | -176 | -164 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 53 | -151 | 4 | 35 | -27 |
Depreciation & Amortization (Cash Flow) | 90 | 92 | 60 | 19 | 10 |
Income After Depreciation & Amortization | -37 | -243 | -56 | 16 | -37 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.10 | 68.64 | 57.33 | 27.89 | NA |
Diluted EPS Before Non-Recurring Items | -1.16 | -1.42 | -0.92 | -0.44 | NA |
Diluted Net EPS (GAAP) | -3.68 | -3.58 | -0.30 | -6.32 | NA |
Fiscal Year end for Ayr Wellness Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 118.04 | 114.84 | 114.39 | 116.74 |
Cost Of Goods | NA | 67.38 | 65.45 | 66.26 | 60.09 |
Gross Profit | NA | 50.66 | 49.38 | 48.13 | 56.65 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 52.63 | 58.92 | 49.58 | 61.19 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.97 | -9.54 | -1.45 | -4.54 |
Non-Operating Income | NA | -77.27 | -0.40 | 6.50 | -3.28 |
Interest Expense | NA | 17.62 | 10.57 | 10.77 | 10.50 |
Pretax Income | NA | -96.85 | -20.51 | -5.73 | -18.32 |
Income Taxes | NA | 11.48 | 9.78 | 13.54 | 12.89 |
Minority Interest | NA | 0.00 | -2.31 | -1.02 | -0.71 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -108.34 | -30.29 | -19.27 | -31.20 |
Extras & Discontinued Operations | NA | 0.00 | -0.67 | -1.00 | 0.56 |
Net Income (GAAP) | NA | -108.34 | -28.65 | -19.25 | -29.93 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 97.88 | 76.95 | 76.56 | 72.76 |
Diluted EPS Before Non-Recurring Items | NA | -0.27 | -0.36 | -0.24 | -0.42 |
Diluted Net EPS (GAAP) | NA | -1.08 | -0.24 | -0.25 | -0.41 |